VIST vs BMA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

VIST

32.0
AI Score
VS
VIST Wins

BMA

31.2
AI Score

Investment Advisor Scores

VIST

32score
Recommendation
AVOID NEW MONEY

BMA

31score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric VIST BMA Winner
Forward P/E 6.2735 3.0979 BMA
PEG Ratio 0 0.4681 Tie
Revenue Growth 102.3% 21.4% VIST
Earnings Growth 29.8% 28.2% VIST
Tradestie Score 32.0/100 31.2/100 VIST
Profit Margin 23.6% 8.4% VIST
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

VIST 1M: -16.6% · 3M: +5.0% BMA 1M: -18.4% · 3M: -31.6%

Current Technical Phase

VIST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 34.6 · Price: $64.25

BMA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.7%), weak momentum, RSI 22

RSI (14): 21.7 · Price: $64.55

Fundamentals Snapshot

Metric VIST BMA
Market Cap — —
Forward P/E 0.4 0.0
Trailing P/E 8.5 16.6
Revenue (TTM) — —
Revenue Growth 1.0% 0.0%
Gross Margin 0.8% 1.0%
Operating Margin 0.4% 0.3%
EPS 7.60 3.93
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, VIST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.